COMBINATION THERAPY COMPRISING ANTI-CD20 AND ANTI-CD40 ANTIBODIES FOR THE TREATMENT OF B CELL-RELATED CANCERS

• 收藏
• 分享

专利权人:

NOVARTIS VACCINES AND DIAGNOSTICS INC.

发明人:

LONG, LI,LUQMAN, MOHAMMAD,YABANNAVAR, ASHA,ZAROR, ISABEL

申请号：

HK07113503.6

公开号：

HK1106736B

申请日:

2007.12.11

申请国别(地区):

HK

年份:

2012

代理人:

摘要：

Methods of treating a human subject for a cancer characterized by neoplastic B cell growth are provided. The methods comprise administering combination antibody therapy to the subject, where an effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof in combination with an anti-CD20 antibody or antigen-binding fragment thereof is administered to the subject. The invention further comprises pharmaceutical compositions with combinations of these antibodies in a pharmaceutically acceptable carrier.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/